Actively Recruiting
The Brest Registry of Stroke Collecting Confirmed Stroke Cases to Calculate Incidence and Study Outcomes
Led by University Hospital, Brest · Updated on 2023-05-26
15000
Participants Needed
1
Research Sites
539 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Brest
Lead Sponsor
S
Santé publique France-InVS (Institut National de Veille sanitaire)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are gathering all confirmed cases of stroke within a specific geographic area to calculate how often strokes occur. The study aims to provide data on stroke incidence, mortality rates in the short and long term, and medication safety, especially concerning bleeding risks related to anticoagulants. It also explores socio-economic impacts, clinical and genetic predictors of stroke outcomes, and stroke identification algorithms using existing data. This observational registry collects information on ischemic strokes, hemorrhagic strokes, and cerebral venous thrombosis diagnosed after December 31, 2007, in individuals aged over 15 years living in defined communes. It collaborates with other regional registries to analyze bleeding risks from different anticoagulants and follows patients over time to study mortality and recurrence patterns. Participants are included based on validated stroke diagnoses and residence in the specified area. The study tracks the type of stroke at diagnosis and follows patient outcomes annually for up to 10 years. This long-term monitoring includes clinical data collection to assess mortality, recurrence, and the impact of socio-economic factors, supporting improvements in stroke management and care quality.
CONDITIONS
Brief Title
Population-based Brest Stroke Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of ischemic stroke
- Confirmed diagnosis of non-traumatic intracranial hematoma
- Confirmed diagnosis of cerebral venous thrombosis
- Diagnosis made after December 31, 2007
- Age over 15 years at time of diagnosis
- Residence in one of the 79 predefined communes at diagnosis
You will not qualify if you...
- Age 15 years or younger
- Diagnosis of aneurysmal subarachnoid hemorrhage cerebrovascular disease
- Diagnosis made before January 1, 2008
- Unconfirmed diagnosis
- Residence outside the predefined study area at diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who have had a confirmed stroke diagnosis are observed to collect data on stroke incidence, mortality, and clinical outcomes over time.
Annual visits for up to 10 years
Trial Site Locations
Total: 1 location
1
CHRU de Brest
Brest, France, 29200
Actively Recruiting
Research Team
S
Serge TIMSIT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here